DK0667859T3 - Molekylmærkning med 2-hydrazinopyridinderivater - Google Patents
Molekylmærkning med 2-hydrazinopyridinderivaterInfo
- Publication number
- DK0667859T3 DK0667859T3 DK93924157T DK93924157T DK0667859T3 DK 0667859 T3 DK0667859 T3 DK 0667859T3 DK 93924157 T DK93924157 T DK 93924157T DK 93924157 T DK93924157 T DK 93924157T DK 0667859 T3 DK0667859 T3 DK 0667859T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- compound
- date
- sec
- moiety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929223168A GB9223168D0 (en) | 1992-11-05 | 1992-11-05 | Improvements in molecule labelling |
PCT/GB1993/002259 WO1994010149A1 (en) | 1992-11-05 | 1993-11-03 | Molecule labelling using 2-hydraninopyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0667859T3 true DK0667859T3 (da) | 2000-10-16 |
Family
ID=10724568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93924157T DK0667859T3 (da) | 1992-11-05 | 1993-11-03 | Molekylmærkning med 2-hydrazinopyridinderivater |
Country Status (19)
Country | Link |
---|---|
US (1) | US5679778A (fi) |
EP (1) | EP0667859B1 (fi) |
JP (1) | JP3542597B2 (fi) |
KR (1) | KR100295545B1 (fi) |
AT (1) | ATE195730T1 (fi) |
AU (1) | AU676863B2 (fi) |
CA (1) | CA2148595C (fi) |
DE (1) | DE69329293T2 (fi) |
DK (1) | DK0667859T3 (fi) |
ES (1) | ES2150950T3 (fi) |
FI (1) | FI113044B (fi) |
GB (1) | GB9223168D0 (fi) |
GR (1) | GR3034883T3 (fi) |
HK (1) | HK1013420A1 (fi) |
HU (1) | HU226459B1 (fi) |
NO (1) | NO305364B1 (fi) |
NZ (1) | NZ257376A (fi) |
PT (1) | PT667859E (fi) |
WO (1) | WO1994010149A1 (fi) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942210A (en) * | 1994-11-15 | 1999-08-24 | Cytogen Corporation | Methods for lyoprotecting a macromolecule using tricine |
US5919934A (en) * | 1997-02-19 | 1999-07-06 | The George Washington University | Compounds, compositions, and methods for cancer imaging and therapy |
ES2398118T3 (es) | 1997-04-30 | 2013-03-13 | The Board Of Trustees Of The Leland Stanford Junior University | Procedimiento de formación de imágenes de muerte celular in vivo |
US6403054B1 (en) * | 1997-05-28 | 2002-06-11 | Bristol-Myers Squibb Pharma Company | Ternary ligand complexes useful as radiopharmaceuticals |
US6844333B1 (en) * | 1999-03-26 | 2005-01-18 | The Trustees Of The University Of Pennsylvania | Method of treating atherosclerosis |
AU2001247697B2 (en) * | 2000-03-22 | 2006-06-22 | Solulink, Incorporated | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
US6686461B1 (en) | 2000-03-22 | 2004-02-03 | Solulink Bioscience, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
US7102024B1 (en) | 2000-08-01 | 2006-09-05 | Schwartz David A | Functional biopolymer modification reagents and uses thereof |
US6843980B2 (en) | 2001-04-03 | 2005-01-18 | Theseus Imaging, Corp. | Methods for using annexin for detecting cell death in vivo and treating associated conditions |
EP1381839A4 (en) | 2001-04-03 | 2005-10-12 | Univ Leland Stanford Junior | METHOD FOR THE IMAGE OF CELL DEOD IN VIVO |
GB0130845D0 (en) * | 2001-12-22 | 2002-02-06 | James Peter | Analysis |
US7158353B2 (en) * | 2003-11-06 | 2007-01-02 | Seagate Technology Llc | Magnetoresistive sensor having specular sidewall layers |
JP5107716B2 (ja) * | 2004-11-05 | 2012-12-26 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | 分子治療用生分解性リンカー |
CN103403011A (zh) * | 2011-01-31 | 2013-11-20 | Eth苏黎世公司 | 三官能交联试剂 |
JP6415979B2 (ja) | 2011-06-03 | 2018-10-31 | スリーエム イノベイティブ プロパティズ カンパニー | ヒドラジノ1h−イミダゾキノリン−4−アミン及びこれから調製された複合体 |
MX347240B (es) | 2011-06-03 | 2017-04-20 | 3M Innovative Properties Co | Ligadores heterobifuncionales con segmentos polietilenglicol y conjugados modificadores de la respuesta inmunitaria elaborados a partir de los mismos. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
IL93432A (en) * | 1989-02-24 | 1994-02-27 | Johnson Mathey Inc | Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions |
US5112953A (en) * | 1989-12-29 | 1992-05-12 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
-
1992
- 1992-11-05 GB GB929223168A patent/GB9223168D0/en active Pending
-
1993
- 1993-11-03 WO PCT/GB1993/002259 patent/WO1994010149A1/en active IP Right Grant
- 1993-11-03 EP EP93924157A patent/EP0667859B1/en not_active Expired - Lifetime
- 1993-11-03 AT AT93924157T patent/ATE195730T1/de active
- 1993-11-03 DK DK93924157T patent/DK0667859T3/da active
- 1993-11-03 HU HU9501275A patent/HU226459B1/hu unknown
- 1993-11-03 DE DE69329293T patent/DE69329293T2/de not_active Expired - Lifetime
- 1993-11-03 KR KR1019950701810A patent/KR100295545B1/ko not_active IP Right Cessation
- 1993-11-03 NZ NZ257376A patent/NZ257376A/en not_active IP Right Cessation
- 1993-11-03 ES ES93924157T patent/ES2150950T3/es not_active Expired - Lifetime
- 1993-11-03 PT PT93924157T patent/PT667859E/pt unknown
- 1993-11-03 AU AU53755/94A patent/AU676863B2/en not_active Expired
- 1993-11-03 JP JP51085194A patent/JP3542597B2/ja not_active Expired - Lifetime
- 1993-11-03 CA CA002148595A patent/CA2148595C/en not_active Expired - Lifetime
- 1993-11-03 US US08/432,204 patent/US5679778A/en not_active Expired - Lifetime
-
1995
- 1995-05-04 FI FI952141A patent/FI113044B/fi not_active IP Right Cessation
- 1995-05-04 NO NO951751A patent/NO305364B1/no not_active IP Right Cessation
-
1998
- 1998-12-22 HK HK98114895A patent/HK1013420A1/xx not_active IP Right Cessation
-
2000
- 2000-11-22 GR GR20000402572T patent/GR3034883T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100295545B1 (ko) | 2001-09-17 |
ES2150950T3 (es) | 2000-12-16 |
JPH08502744A (ja) | 1996-03-26 |
KR950704256A (ko) | 1995-11-17 |
FI952141A (fi) | 1995-05-04 |
ATE195730T1 (de) | 2000-09-15 |
NZ257376A (en) | 1996-02-27 |
CA2148595A1 (en) | 1994-05-11 |
HUT72332A (en) | 1996-04-29 |
AU676863B2 (en) | 1997-03-27 |
JP3542597B2 (ja) | 2004-07-14 |
DE69329293T2 (de) | 2000-12-28 |
FI113044B (fi) | 2004-02-27 |
HU226459B1 (en) | 2008-12-29 |
CA2148595C (en) | 2002-05-21 |
FI952141A0 (fi) | 1995-05-04 |
AU5375594A (en) | 1994-05-24 |
PT667859E (pt) | 2001-02-28 |
WO1994010149A1 (en) | 1994-05-11 |
GR3034883T3 (en) | 2001-02-28 |
GB9223168D0 (en) | 1992-12-16 |
NO951751D0 (no) | 1995-05-04 |
HK1013420A1 (en) | 1999-08-27 |
DE69329293D1 (de) | 2000-09-28 |
EP0667859A1 (en) | 1995-08-23 |
NO305364B1 (no) | 1999-05-18 |
EP0667859B1 (en) | 2000-08-23 |
US5679778A (en) | 1997-10-21 |
NO951751L (no) | 1995-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0667859T3 (da) | Molekylmærkning med 2-hydrazinopyridinderivater | |
NO20003133D0 (no) | Anilidderivater, fremstilling og anvendelse derav | |
NO20031490D0 (no) | Alifatisk nitrogenholdig 5-kantet ring-forbindelse | |
KR850003402A (ko) | 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법 | |
KR940000447A (ko) | 티아졸의 분지쇄 알킬아미노유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물 | |
AU3141693A (en) | Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them | |
ATE416186T1 (de) | Phenylethylenamin-derivate | |
FI903917A0 (fi) | Foerfarande foer framstaellning av med metallradionuklider maerkta proteiner. | |
CA2176935A1 (fr) | Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d | |
KR830010072A (ko) | 아미디노 피페리딘 유도체의 제조방법 | |
SE8505716D0 (sv) | Novel compounds and conjugates thereof | |
DK0548338T3 (da) | Fremgangsmåde til fremstilling af cephalosporinmellemprodukter | |
ES2104682T3 (es) | Fluor-compuestos. | |
CA2211385A1 (en) | N-1-carboxyalkyl derivatives of lsd | |
DE50004382D1 (de) | Verfahren zur Herstellung von Guanidinderivaten | |
ES2099963T3 (es) | Sintesis de indoles mediante deshidrogenacion de indolinas. | |
ATE181327T1 (de) | Indolderivate | |
KR960704889A (ko) | 인돌리진 유도체의 제조방법 (Process for the preparation of indolizine derivatives) | |
KR920002550A (ko) | 6-알킬피리다진 유도체, 그의 제법 및 그를 함유하는 약학 조성물 | |
TH16053A (fi) | ||
DK0429751T3 (da) | Substituerede 3-aminosydnoniminer, fremgangsmåde til deres fremstilling og deres anvendelse | |
KR920004377A (ko) | 피리딘카복실산 아미드 유도체 및 이를 함유하는 약제학적 조성물 | |
KR910007952A (ko) | 신규 안트라사이클린 글리코사이드 유도체 | |
AR017362A1 (es) | Compuestos heterociclicos fusionados seleccionados entre derivados de pirrolo-furo- y tieno-, piridina, pirazina, piridazina, y pirimidina, su uso, unprocedimiento para fabricarlos, preparaciones farmaceuticas que los contienen y compuestos utiles como intermediarios para prepararlos | |
KR940014350A (ko) | 신규 1, 6-디아미노 피리미딘-4-티온 유도체 및 이의 제조방법 |